The global automated and closed cell therapy processing system market size accounted for USD 1.51 billion in 2024, grew to USD 1.86 billion in 2025, and is expected to be worth around USD 12.40 billion by 2034, poised to grow at a CAGR of 23.44% between 2024 and 2034. The North America automated and closed cell therapy processing system market size is predicted to increase from USD 690 million in 2024 and is estimated to grow at the fastest CAGR of 23.57% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Automated and Closed Cell Therapy Processing System Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Automated and Closed Cell Therapy Processing System Market, by Workflow, 2024-2034
8.1.1 Cryopreservation
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Fill-finish
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Separation
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Expansion
8.1.4.1. Market Revenue and Forecast (2021-2034)
8.1.5. Apheresis
8.1.5.1. Market Revenue and Forecast (2021-2034)
8.1.6. Others
8.1.6.1. Market Revenue and Forecast (2021-2034)
9.1. Automated and Closed Cell Therapy Processing System Market, by Type, 2024-2034
9.1.1. Stem Cell Therapy
9.1.1.1. Market Revenue and Forecast (2021-2034)
9.1.2. Non-stem Cell Therapy
9.1.2.1. Market Revenue and Forecast (2021-2034)
10.1. Automated and Closed Cell Therapy Processing System Market, by Scale, 2024-2034
10.1.1. Commercial Scale
10.1.1.1. Market Revenue and Forecast (2021-2034)
10.1.2. R&D Scale
10.1.2.1. Market Revenue and Forecast (2021-2034)
11.1. North America
11.1.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.1.2. Market Revenue and Forecast, by Type (2021-2034)
11.1.3. Market Revenue and Forecast, by Scale (2021-2034)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.1.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.1.4.3. Market Revenue and Forecast, by Scale (2021-2034)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.1.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.1.5.3. Market Revenue and Forecast, by Scale (2021-2034)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.2.2. Market Revenue and Forecast, by Type (2021-2034)
11.2.3. Market Revenue and Forecast, by Scale (2021-2034)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.2.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.2.4.3. Market Revenue and Forecast, by Scale (2021-2034)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.2.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.2.5.3. Market Revenue and Forecast, by Scale (2021-2034)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.2.6.2. Market Revenue and Forecast, by Type (2021-2034)
11.2.6.3. Market Revenue and Forecast, by Scale (2021-2034)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.2.7.2. Market Revenue and Forecast, by Type (2021-2034)
11.2.7.3. Market Revenue and Forecast, by Scale (2021-2034)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.3.2. Market Revenue and Forecast, by Type (2021-2034)
11.3.3. Market Revenue and Forecast, by Scale (2021-2034)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.3.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.3.4.3. Market Revenue and Forecast, by Scale (2021-2034)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.3.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.3.5.3. Market Revenue and Forecast, by Scale (2021-2034)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.3.6.2. Market Revenue and Forecast, by Type (2021-2034)
11.3.6.3. Market Revenue and Forecast, by Scale (2021-2034)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.3.7.2. Market Revenue and Forecast, by Type (2021-2034)
11.3.7.3. Market Revenue and Forecast, by Scale (2021-2034)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.4.3. Market Revenue and Forecast, by Scale (2021-2034)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.4.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.4.4.3. Market Revenue and Forecast, by Scale (2021-2034)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.4.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.4.5.3. Market Revenue and Forecast, by Scale (2021-2034)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.4.6.2. Market Revenue and Forecast, by Type (2021-2034)
11.4.6.3. Market Revenue and Forecast, by Scale (2021-2034)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.4.7.2. Market Revenue and Forecast, by Type (2021-2034)
11.4.7.3. Market Revenue and Forecast, by Scale (2021-2034)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.5.3. Market Revenue and Forecast, by Scale (2021-2034)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.5.4.2. Market Revenue and Forecast, by Type (2021-2034)
11.5.4.3. Market Revenue and Forecast, by Scale (2021-2034)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Workflow (2021-2034)
11.5.5.2. Market Revenue and Forecast, by Type (2021-2034)
11.5.5.3. Market Revenue and Forecast, by Scale (2021-2034)
12.1. Lonza
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. BioSpherix
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Cellares
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Sortorius
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cytiva
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. ThermoGenesis Holdings Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Thermo Fisher Scientific Inc
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample